Xoma | XOMA - Current Assets

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $110.71M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Agenus USD 133.95M 120.61M Sep/2025
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Ardelyx USD 367.98M 16.42M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
BioMarin Pharmaceutical USD 3.85B 49.21M Sep/2025
Celldex Therapeutics USD 604.34M 44.06M Sep/2025
Curis USD 14.42M 10.39M Jun/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Incyte USD 5.02B 746.01M Dec/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Prothena USD 339.97M 45.51M Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025